European Committee for Treatment and Research in Multiple Sclerosis and European Academy of Neurology consensus on vaccination in people with multiple sclerosis: Improving immunization strategies in the era of highly active immunotherapeutic drugs
European Journal of Neurology · 2023-08 · 30 (8) · 2144-2176
DOI: 10.1111/ene.15809 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Neurology, online erschienen am 09.06.2023. Verfasst von Susana Otero-Romero und 14 weiteren Autor:innen. Beteiligte Einrichtung: Preventive Medicine and Epidemiology Department, Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain. Hauptthemen laut MEDLINE: Multiple Sclerosis, Neurology. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 104 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background and purpose With the new highly active drugs available for people with multiple sclerosis (pwMS), vaccination becomes an essential part of the risk management strategy. We aimed to develop a European evidence‐based consensus for the vaccination strategy of pwMS who are candidates for disease‐modifying therapies (DMTs).
Methods
This work was conducted by a multidisciplinary working group using formal consensus methodology. Clinical questions (defined as population, interventions and outcomes) considered all authorized DMTs and vaccines. A systematic literature search was conducted and quality of evidence was defined according to the Oxford Centre for Evidence‐Based Medicine Levels of Evidence. The recommendations were formulated based on the quality of evidence and the risk–benefit balance.
Results
Seven questions, encompassing vaccine safety, vaccine effectiveness, global vaccination strategy and vaccination in subpopulations (pediatric, pregnant women, elderly and international travelers) were considered. A narrative description of the evidence considering published studies, guidelines and position statements is presented. A total of 53 recommendations were agreed by the working group after three rounds of consensus.
Conclusion
This first European consensus on vaccination in pwMS proposes the best vaccination strategy according to current evidence and expert knowledge, with the goal of homogenizing the immunization practices in pwMS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Preventive Medicine and Epidemiology Department, Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain.
- Multiple Sclerosis Centre of Catalonia, Department of Neurology/Neuroimmunology, Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain.
- CRCSEP Nice, CHU de Nice Pasteur2, Universite ́ Nice Cote d'Azur UR2CA-URRIS, Nice, France.
- Fundación Santa Fe de Bogotá, Bogotá, Colombia.
- School of Medicine, Universidad de los Andes, Bogotá, Colombia.
- Barts and The London School of Medicine and Dentistry, Blizard Institute, Queen Mary University of London, London, UK.
ORCID-Profile: Susana Otero-Romero, Christine Lebrun-Frénay, Mauricio Farez, Massimo Filippi, Bernhard Hemmer, Melinda Magyari, Celia Oreja-Guevara
Zitieren
APA
Otero-Romero, S., Lebrun-Frénay, C., Reyes, S., Amato, M. P., Campins, M., Farez, M., Filippi, M., Hacohen, Y., Hemmer, B., Juuti, R., Magyari, M., Oreja-Guevara, C., Siva, A., Vukusic, S., & Tintoré, M. (2023). European Committee for Treatment and Research in Multiple Sclerosis and European Academy of Neurology consensus on vaccination in people with multiple sclerosis: Improving immunization strategies in the era of highly active immunotherapeutic drugs. European Journal of Neurology, 30(8), 2144-2176. https://doi.org/10.1111/ene.15809
Vancouver
Otero-Romero S, Lebrun-Frénay C, Reyes S, Amato MP, Campins M, Farez M, et al. European Committee for Treatment and Research in Multiple Sclerosis and European Academy of Neurology consensus on vaccination in people with multiple sclerosis: Improving immunization strategies in the era of highly active immunotherapeutic drugs. European Journal of Neurology. 2023;30(8):2144-2176. doi:10.1111/ene.15809
BibTeX
@article{OteroRomero2023,
author = {Otero-Romero, Susana and Lebrun-Frénay, Christine and Reyes, Saúl and Amato, Maria Pia and Campins, Magda and Farez, Mauricio and Filippi, Massimo and Hacohen, Yael and Hemmer, Bernhard and Juuti, Rosa and Magyari, Melinda and Oreja-Guevara, Celia and Siva, Aksel and Vukusic, Sandra and Tintoré, Mar},
title = {European Committee for Treatment and Research in Multiple Sclerosis and European Academy of Neurology consensus on vaccination in people with multiple sclerosis: Improving immunization strategies in the era of highly active immunotherapeutic drugs},
journal = {European Journal of Neurology},
year = {2023},
volume = {30},
number = {8},
pages = {2144--2176},
doi = {10.1111/ene.15809}
}
EUVIMED